Page last updated: 2024-11-05

n-methylcarbamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-methylcarbamate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21584661
CHEBI ID193111
MeSH IDM0074066

Synonyms (7)

Synonym
n-methyl carbamate
CHEBI:193111
n-methylcarbamate
A832508
(methyl)carbamate
UFEJKYYYVXYMMS-UHFFFAOYSA-M
AKOS024437972

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" To study the mechanism of this toxicity, suspensions of mouse hepatocytes were tested as an in vitro model system suitable for the study of the relationship between (i) the toxic potential of formamides, (ii) their metabolism to N-alkylcarbamoylating species, and (iii) their ability to deplete hepatic glutathione pools."( Cytotoxicity and metabolism of the hepatotoxin N-methylformamide and related formamides in mouse hepatocytes.
Gescher, A; Mráz, J; Shaw, AJ, 1988
)
0.27
" None of these compounds alone in the dosage used produced toxic signs; however, carboxylesterase (CarbE) activity in a variety of organs including brain, muscle, liver, and plasma was significantly reduced, while acetylcholinesterase (AChE) activity was unchanged."( Role of carboxylesterases in the prevention and potentiation of N-methylcarbamate toxicity.
Dettbarn, WD; Gupta, RC, 1993
)
0.29

Dosage Studied

ExcerptRelevanceReference
" None of these compounds alone in the dosage used produced toxic signs; however, carboxylesterase (CarbE) activity in a variety of organs including brain, muscle, liver, and plasma was significantly reduced, while acetylcholinesterase (AChE) activity was unchanged."( Role of carboxylesterases in the prevention and potentiation of N-methylcarbamate toxicity.
Dettbarn, WD; Gupta, RC, 1993
)
0.29
" Next, dose-response data were collected for each carbamate, using four doses and control, with motor activity testing beginning 15 min after dosing and tissue collection at 40-45 min."( Time-course, dose-response, and age comparative sensitivity of N-methyl carbamates in rats.
Lowit, AB; McDaniel, KL; Moser, VC; Phillips, PM, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amino-acid anion
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (60)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (16.67)18.7374
1990's13 (21.67)18.2507
2000's18 (30.00)29.6817
2010's18 (30.00)24.3611
2020's1 (1.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.54%)6.00%
Case Studies1 (1.54%)4.05%
Observational0 (0.00%)0.25%
Other63 (96.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]